The ROE as of November 2024 (TTM) for OncoSec Medical Incorporated (ONCS) is -154.68%

According to OncoSec Medical Incorporated’s latest financial reports and current stock price. The company's current ROE is -154.68%. This represents a change of -173.54% compared to the average of 210.33% of the last 4 quarters.

OncoSec Medical Incorporated (ONCS) Historical ROE (quarterly & annually)

How has ONCS ROE performed in the past?

The mean historical ROE of OncoSec Medical Incorporated over the last ten years is -182.11%. The current -154.68% ROE has changed -15.06% with respect to the historical average. Over the past ten years (40 quarters), ONCS's ROE was at its highest in in the October 2022 quarter at 895.52%. The ROE was at its lowest in in the January 2020 quarter at -429.43%.

OncoSec Medical Incorporated (ONCS) ROE by Quarter and Year

Discovering the peaks and valleys of OncoSec Medical Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OncoSec Medical Incorporated (ONCS) Average ROE

How has ONCS ROE performed in the past?

The current ROE of OncoSec Medical Incorporated (ONCS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

OncoSec Medical Incorporated (ONCS) ROE vs. Peers

How is ONCS’s ROE compared to its peers?

OncoSec Medical Incorporated’s ROE is greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Palisade Bio, Inc. (-148.31%), greater than Unicycive Therapeutics, Inc. (-374.14%), less than Apexigen, Inc. (48.27%), greater than Immix Biopharma, Inc. (-102.10%), less than Phio Pharmaceuticals Corp. (0%), greater than 180 Life Sciences Corp. (-134.57%), greater than Navidea Biopharmaceuticals, Inc. (-559.06%), greater than First Wave BioPharma, Inc. (-173.56%), greater than Dermata Therapeutics, Inc. (-28.76%), greater than Revelation Biosciences, Inc. (-247.40%), greater than Panbela Therapeutics, Inc. (-311.33%), less than ContraFect Corporation (304.71%), less than Quoin Pharmaceuticals, Ltd. (376.50%), greater than Allarity Therapeutics, Inc. (-126.19%), greater than Kiromic BioPharma, Inc. (-328.22%), less than Virax Biolabs Group Limited (327.18%), greater than Biodexa Pharmaceuticals Plc (-115.10%), greater than null (-101.74%),

Build a custom stock screener for OncoSec Medical Incorporated (ONCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSec Medical Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoSec Medical Incorporated (ONCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoSec Medical Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.